T3 Part 9

Register Now - $40

1 hour
1 AMA PRA Category 1 Credit™
1 Nursing Contact Hour


Neal Rouzier, MD
Faculty Chairman


1 Hour Courses , Thyroid

This course is a continuation of the same theme proving high dose replacement T3 does not cause harm nor appears to be a cardiovascular risk.  In this course, we will review the successful use of thyroid hormone in high doses.  Dr. Rouzier does not advocate doing this, whereas the purpose is to provide credence and confidence that our usual prescription of thyroid hormone does not cause any adverse CVD harm.


Upon completion of this workshop, the healthcare professional will be able to:

  1. While hyperthyroidism is a significant cardiovascular risk factor causing 20% premature death rate, participants will identify how HDT treatment does not appear to be a significant cardiovascular risk.
  2. Interpret the myths of HDT risk factors, the first being that HDT can increase the risk of developing osteoporosis and the second is that it increases cardiovascular risk.
  3. Recognize the cardiovascular risks of HDT appear to be low. HDT is at least as safe as or safer than many psychiatric medications.
  4. Recall how the chronic misuse of terminology in literature (i.e. calling all suppressed TSH or elevations of thyroid hormone to mean hyperthyroidism) are at best confusing in determining the difference between HDT and hyperthyroidism.